FDA Chief Says He Wants Gene Therapy Head Prasad to Return

FDA Chief Says He Wants Gene Therapy Head Prasad to Return

US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head of gene therapy and vaccines, to return to the FDA after his abrupt departure last week.

Top FDA vaccine regulator under Trump, Vinay Prasad, ousted amid conservative criticism

The U.S. Food and Drug Administration’s White Oak campus in Silver Spring, Maryland. MUST CREDIT: Maansi Srivastava/For The Washington Post Vinay Prasad, a critic of broadly administering coronavirus shots who became the Food and Drug Administration’s top vaccine and gene therapy regulator in May, was ousted Tuesday,(July 29) according to two people familiar with the situation. Prasad had recently come under fire from some Republicans and conser…

StockWatch: As Prasad Exits FDA, Analysts See Benefit for Sarepta, CGT Stocks

Sarepta Therapeutics (NASDAQ: SRPT) and other cell and gene therapy (CGT) developers, battered in recent months by clinical, regulatory, and/or commercial setbacks, will likely benefit from the sudden departure of Vinayak (Vinay) Prasad, MD, as director of the FDA’s Center for Biologics Evaluation and Research (CBER), five analysts have told investors in recent days. Prasad—who took on additional roles as the FDA’s chief medical and scientific o…